British Journal of Clinical Pharmacology · 1983 · 13 citations · 4 references
MedicinePharmacokineticsPharmacologyCardiovascular PharmacotherapyDrug ClearancePharmacodynamicsCardiovascular DiseaseCardiovascular Drug MonitoringCardiovascular PharmacologyCoronary Artery DiseaseDrug Half-lifeIschemic Heart DiseaseCoronary Artery Disease PharmacotherapyDrug Elimination Half-lifeIsosorbide DinitratePharmacokinetics Of Cardiovascular DrugsPlasma Concentration-time AnalysisPlasma Concentration-time Profile AnalysisPlasma PharmacokineticsTerminal Half-life Estimation
The plasma concentration of isosorbide dinitrate (ISDN) was monitored up to 24 h after a chronic oral dose of 60 mg in six patients with coronary artery disease. A terminal half-life of 7.7 +/- 2.6 h (mean +/- s.d.) was observed. The presence of this prolonged disappearance phase provided at least a partial explanation for the observed accumulation of ISDN in plasma after chronic dosing on a six hourly regimen.
4
Pharmacokinetics of intravenous and oral isosorbide-5-mononitrate
U. Abshagen, G Betzien, R. Endele et al. · European Journal of Clinical Pharmacology · 1981 · 111 citations